PMV Pharmaceuticals (PMVP) Price/FCF Ratio: History & Chart

PMV Pharmaceuticals, Inc.(PMVP)

Biotechnology · Princeton, NJ

$1.61-0.17 (-9.55%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About PMV Pharmaceuticals, Inc.

PMV Pharmaceuticals, Inc. operates as a precision oncology company focused on discovering and developing both small molecule and tumor-agnostic therapies to address p53 mutations in cancer patients. Their leading experimental drug, PC14586, is a small molecule designed to correct the p53 protein specifically when it contains the Y220C mutation, thereby restoring its natural, functional state. The company is also progressing a pipeline of other programs targeting various mutant p53 forms, including Wild-type p53 Induced-Phosphatase, R282W, R273H, and other prevalent p53 hotspot mutations. Originally known as PJ Pharmaceuticals, Inc., the firm rebranded to PMV Pharmaceuticals, Inc. in July 2013. The company was founded in 2013 and has its main operational base in Cranbury, New Jersey.

Princeton, NJ

54 employees

www.pmvpharma.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: David H. Mack

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
PMV Pharmaceuticals, Inc. (PMVP)	$85.86M	N/A	N/A	N/A	N/A
Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›	$87.27M	N/A	N/A	N/A	N/A
Cognition Therapeutics, Inc. (CGTX)vs ›	$84.13M	N/A	N/A	N/A	N/A
Atara Biotherapeutics, Inc. (ATRA)vs ›	$87.85M	N/A	N/A	N/A	N/A
CareCloud, Inc. (CCLD)vs ›	$87.96M	4.06	5.32	4.50	8.18
ProMIS Neurosciences, Inc. (PMN)vs ›	$82.59M	N/A	N/A	N/A	N/A
Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs ›	$82.53M	N/A	N/A	N/A	N/A
Cardiff Oncology, Inc. (CRDF)vs ›	$82.47M	N/A	17.74	16.00	17.53
electroCore, Inc. (ECOR)vs ›	$89.44M	N/A	N/A	N/A	N/A
LENSAR Inc (LNSR)vs ›	$82.29M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

PMV Pharmaceuticals, Inc. (PMVP)

$85.86M

N/A

Neumora Therapeutics, Inc. Common Stock (NMRA)vs ›

$87.27M

N/A

Cognition Therapeutics, Inc. (CGTX)vs ›

$84.13M